Fig. 5From: Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapyChanges in mean hemoglobin concentration of HCV infected patients during Sofosbuvir and Ribavirin treatment. (A) Changes in mean Hb concentration of overall patients. (B) Changes in mean Hb concentration with reference of ITPA rs1127354 CC and CA. Base line (BL), Month of treatment (M1, M2, M3, M4, M5, M6)Back to article page